Precision Pharmacogenetics and Genotype Class Based Prediction of Mavacamten Response in Obstructive Hypertrophic Cardiomyopathy

by | Feb 13, 2026 | Clinical Trials | 0 comments

​ Conditions: Hypertrophic Cardiomyopathy (HCM)

Interventions: Other: Observational study, no new intervention offered

Sponsors: University of Manchester

Not yet recruiting Conditions: Hypertrophic Cardiomyopathy (HCM)
Interventions: Other: Observational study, no new intervention offered
Sponsors: University of Manchester
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *